SalemNews.com, Salem, MA

Opinion

April 5, 2013

Our view: Time to end drugmakers' 'pay for delay'

Americans struggling to meet health care costs know firsthand how expensive prescription drugs can be. They may not know how drug companies often work together to keep costs artificially high.

The scheme is called “pay for delay.” Essentially, makers of brand-name drugs pay the makers of generic drugs not to challenge their patents or delay their attempts to make less-expensive alternatives. The brand-name makers then get to continue to charge whatever they want for the medicine, and the generic firms get a little cash for standing on the sidelines. The only losers in the deal are the patients who need the drugs and increasingly can’t afford them.

Writing in The Huffington Post, Laura Etherton, U.S. PIRG’s health care policy analyst, explained how the deals work:

“Brand-name Plavix costs about $205 for a 30-day supply,” Etherton wrote. “The generic, not that it’s available, costs about $13. But consumers were stuck paying the higher price for far longer than they otherwise might have.

“That’s because in 2006, Bristol-Myers Squibb paid the generic drugmaker Apoti to delay bringing the generic to market for five years,” Etherton continued. “Without competition, Bristol-Myers Squibb was able to keep making $3.4 billion a year in sales on the brand-name drug.”

The Federal Trade Commission says such deals violate the Sherman Antitrust Act and cost patients billions of dollars a year. In a case argued before the Supreme Court last week, the FTC argued that when Solvay Pharmaceuticals paid another company, Actavis, not to produce a less-expensive version of Solvay’s low-testosterone drug AndroGel, it constituted an unlawful restraint of trade. Not surprisingly, brand-name and generic drugmakers have united to fight the lawsuit.

The pay for delay practice developed as a way to get around the 1984 Hatch-Waxman Act, which prodded generic drugmakers to challenge patents on brand-name drugs, in the hopes of lowering costs for consumers.

Text Only | Photo Reprints
Opinion

AP Video
Judge Ponders Overturning Colo. Gay Marriage Ban Airlines Halt Travel to Israel Amid Violence NYPD Chief Calls for 'use of Force' Retraining VA Nominee McDonald Goes Before Congress Bush: Don't Worry, Sugarland Isn't Breaking Up US Official: Most Migrant Children to Be Removed Police Probing Brooklyn Bridge Flag Switch CDC Head Concerned About a Post-antibiotic Era Raw: First Lady Says `Drink Up' More Water Courts Conflicted Over Healthcare Law Holder Urges Bipartisanship on Immigration Raw: Truck, Train Crash Leads to Fireball US Airlines Cancel Israel Flights Obama Signs Workforce Training Law Crash Victims' Remains Reach Ukraine-held City Diplomatic Push Intensifies to End War in Gaza Cat Fans Lap Up Feline Film Festival Michigan Plant's Goal: Flower and Die Veteran Creates Job During High Unemployment
Comments Tracker
Roll Call
Helium debate
Helium